ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 1 filers reported holding ANTARES PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $426,000 | -99.0% | 104 | -99.1% | 0.00% | -100.0% |
| Q4 2021 | $41,018,000 | -69.0% | 11,490 | -68.4% | 0.01% | -68.8% |
| Q3 2021 | $132,437,000 | -11.9% | 36,385 | +6.2% | 0.03% | -5.9% |
| Q2 2021 | $150,337,000 | +2235.9% | 34,246 | +2023.1% | 0.03% | +1600.0% |
| Q4 2020 | $6,436,000 | +47.8% | 1,613 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $4,355,000 | -95.0% | 1,613 | -94.9% | 0.00% | -95.7% |
| Q2 2020 | $86,603,000 | +15.4% | 31,494 | -1.0% | 0.02% | +9.5% |
| Q1 2020 | $75,071,000 | – | 31,811 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 500,000 | $2,180,000 | 4.34% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,535,727 | $11,056,000 | 3.87% |
| Sargent Investment Group, LLC | 3,596,250 | $15,680,000 | 3.72% |
| Rubric Capital Management LP | 9,500,000 | $41,420,000 | 2.61% |
| PERKINS CAPITAL MANAGEMENT INC | 541,783 | $2,362,000 | 1.34% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,900,000 | $8,284,000 | 1.14% |
| Venator Capital Management Ltd. | 709,700 | $3,094,000 | 1.05% |
| LEVEL FOUR FINANCIAL, LLC | 120,000 | $523,000 | 0.22% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $875,000 | 0.19% |
| Brown Advisory Securities, LLC | 275,000 | $1,199,000 | 0.19% |